To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites

Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years

Vol: 4| Issue: 3| Number:41| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Design modifications of the uncemented Furlong hip stem result in minor early subsidence but do not affect further stability: a randomized controlled RSA study with 5-year follow-up.

Acta Orthop. 2014 Dec;85(6):556-61.

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

50 patients with primary osteoarthritis undergoing total hip arthroplasty were randomized to receive either the Furlong Active femoral stem or the traditional Furlong HAC femoral stem. The purpose of this study was to evaluate the 3-D migratory patterns of the two stems using radiostereometry. Results after 3 months demonstrated significantly greater subsidence of the Furlong Active stem compared to the Furlong HAC stem, though subsidence of each stem plateaued after 3 months and displayed minor changes through to 5 years. Both groups displayed initial retroversion of the implant at 3 months, though minimal differences through to 5 years thereafter. Clinical outcome significantly improved in both groups over 5 years, with no significant differences detected between groups at 1, 2, or 5 year follow-up.

Publication Funding Details +
Funding:
Industry funded
Sponsor:
JRI Ltd.
Conflicts:
None disclosed

Risk of Bias

6.5/10

Reporting Criteria

14/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

1/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

3/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

The Furlong HAC stem is a well-proven femoral implant that has recently undergone modifications to the lateral fin to prevent fracture of the greater trochanter during insertion. The new stem - the Furlong Active stem - is a shorter cone-shape, double-tapered, and has more rounded medial and lateral edges. Using radiostereometry, this study aimed to compare the migratory patterns of the Furlong HAC and Furlong Active stem as a surrogate for osseointegration and long-term survival of the arthroplasty.

What was the principal research question?

Do design modifications to the Furlong HAC stem to give the Furlong Active stem affect the migratory behaviour, osseointegration and long-term result of total hip arthroplasty up to 5 years after surgery?

Study Characteristics -
Population:
50 patients (mean age: 63 years, mean BMI: 27, 27M/23F) with primary osteoarthritis scheduled for total hip arthroplasty. Patients who had unstable femoral anatomy as determined by radiographs and who were Charnley category C patients were excluded from the study. 45 patients (23M/20F) completed the study to completion at the 5 year endpoint. Surgery for both groups was performed using a posterolateral approach and 8-10 tantalum bone markers (diameter=0.8 mm). Apart from the femoral head used as a marker, all prostheses were pre-marked with tantalum markers at the tip, shoulder and medial collar of the stem.
Intervention:
Furlong Active group: Participants received the Furlong Active stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 9M/16F) (Mean age: 62 years, range: 50-77 years)
Comparison:
Furlong HAC group: Participants received the Furlong HAC stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 18M/7F) (Mean age: 63 years, range: 49-75 years)
Outcomes:
Radiostereometry (RSA) and conventional radiographic examinations were performed to analyze motion of the stem in relation to the tantalum markers implanted in the femur. Stem subsidence (Y-translation) and retroversion (Y-rotation) were primary effect variables. Self-administered Hip Disability and Osteoarthritis Outcome Score (HOOS) was also assessed.
Methods:
RCT: Single-centre
Time:
Radiostereometry (RSA) and conventional radiographic examinations were conducted on the first postoperative day, before weight-bearing and then at 3 months, 1,2 and 5 years (+/-5% time tolerance) postoperatively. Routine clinical follow-up occurred 3 months and 1, 2 and 5 months postoperatively. Hip Disability and Osteoarthritis Outcome Score was evaluated prior to surgery and at 1, 2 and 5 years.

What were the important findings?

  • Significantly greater subsidence of the implant was noted in the Furlong Active group (0.99mm distally) compared to the Furlong HAC group (0.31mm distally) (p=0.0.46). Subsequent subsidence from 3 months to 5 years was not statistically significant in the Furlong Active (p=0.5) or HAC (p=0.06) stem.
  • There was one case of extreme subsidence reported in the Furlong Active group (6.5mm after 3 months) in a patient with BMI 41. Exclusion of this outlier case from the main analysis resulted in a non-significant difference in subsidence between groups (p>0.05).
  • Mean retroversion of the femoral stem was measured at 1.18deg in the Furlong Active group and 0.80deg in the Furlong HAC group after 3 months; the difference between groups was not statistically significant. (p=0.46). From 3 month to 5 years, no significant changes in mean retroversion were noted in either the Furlong Active (p=0.1) or HAC group (p=0.1).
  • Two patients, one in the Furlong HAC group (4.2 degrees) and one in the Furlong Active group (5.1 degree), demonstrated significant retroversion of the stem within the first 3 months after surgery. Between 3 months and 5 years, no further retroversion was noted in either patient.
  • No stem in either group was judged to be loose over the 5 year follow-up period.
  • HOOS scores improved significantly within both groups, without significant difference between groups at 1, 2, or 5 years after surgery.
  • Minor X- and Z-plane translation and rotation of the stem were noted in both groups, and differences were small between groups.

What should I remember most?

In total hip arthroplasty, subsidence of the uncemented Furlong Active femoral stem was significantly greater than the Furlong HAC stem in the first 3 months after surgery, although subsidence in both groups thereafter plateaued, with minimal subsidence occurring in either group from 3 months to 5 years. Both stems displayed initial retroversion of the femoral implant in the first 3 months, but minor changes thereafter to 5 years. No stem in either group was considered loose. Clinical outcome was similar between the Furlong Active and HAC stem throughout the 5-year follow-up.

How will this affect the care of my patients?

Though subsidence of the Furlong Active stem was greater than that of the Furlong HAC stem, early migration did not appear to negatively impact 5-year outcome. Namely, osseointegration of the implant was observed to occur after 3 months, with minimal subsidence migration of either implant from 3 month to 5 years, and no loose components observed. Additionally, retroversion did not appear to substantial differ between stem designs. These findings suggest that similar results may be attained with the new Furlong Active stem relative the standard Furlong HAC stem, and that the new design modifications do not negatively affect integration of the component or clinical results. Nevertheless, additional research in a larger cohort of trials should be considered to confirm the the findings of the current study.

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue